Back to Authors

Rinkes, Inne H.M. Borel

0000-0003-2122-7207

Mayo Clinic

Utrecht University

Citations 1

Novel Benchmark Values for Open Major Anatomic Liver Resection in Non-cirrhotic Patients
Silva, Richard X. Sousa Da , Breuer, Eva , Shankar, Sadhana , Hołówko, Wacław , Coelho, João Santos, Jeddou, Heithem , Sugiura, Teiichi , Ghallab, Mohammed, Silva, Doris Da, Watanabe, Genki , Sakai, Nozomu , Addeo, Pietro , Tzedakis, Stylianos , Bartsch, F. , Balcer, Kaja, Lim, Chétana , Werey, Fabien, López, Víctor , Montero, Luciana Peralta, Clariá, Rodrigo Sanchez, Leiting, Jennifer L. , Vachharajani, Neeta , Hopping, Eve , Andel, Daan, Hagendoorn, Jeroen , Psica, Alicja , Ahn, Keun Soo , Montes, Leonardo A., Gunasekaran, Ganesh , Alcázar, C. , Lim, Jin Hong , Haroon, Muhammad, Lü, Qian , Castaldi, Antonio , Orimo, Tatsuya , Abadía, Teresa, Hasan, Josefina Dib, Kaufmann, Emmanuele F., Wilde, Roeland F. de , Boggi, Ugo , Hernandez‐Alejandro, Roberto, Serrablo, Alejandro , Taketomi, Akinobu , Dong, Jiahong , Hanif, Faisal, Park, Joon Seong , Schwartz, Myron , Ramisch, Diego , Oliveira, Michelle de , Oldhafer, K.J., Kang, Koo Jeong , Lodge, P., Rinkes, Inne H. M. Borel, Thomson, John‐Edwin , Goh, Su Kah , Chapman, William C. , Pekolj, Juan , Scatton, Olivier , Truant, Stéphanie , Lang, Hauke , Bachellier, Philippe , Otsuka, Masayuki, Popescu, Irinel , Cherqui, Daniel , Uesaka, Katsuhiko , Marques, Hugo P. , Grąt, Michał , Petrowsky, Henrik , Ebata, Tomoki , Prachalias, Andreas , Clavien, Pierre‐Alain , Kauffmann, Emanuele F. , Leiting, Jennifer, Chapman, William C , Shankar, Sadhana , Kawakatsu, Shoji , Botea, Florin , Torres, Orlando Jorge Martins , Hirano, Satoshi , Ravaioli, Matteo , Reese, Tim , Montes, Leonardo A., Castaldi, Antonio, Moeckli, Beat , Ruffolo, Luis I. , Hasan, Josefina Dib, Ratti, Francesca , Polak, Wojciech G. , Aldrighetti, Luca , McCormack, Lucas , Toso, Christian , Gugenheim, Jean , Ramia, José Manuel , Cescon, Matteo , Rinkes, Inne H.M. Borel , Noji, Takehiro , Cleary, Sean P. , Regimbeau, Jean‐Marc , Fuks, David , Hasegawa, Kiyoshi , Lesurtel, Mickaël , Adam, René , Boudjéma, Karim , Robles, R

Annals of Surgery | July 19, 2023 | Volume: 278 | Issue: 5 | Pages: 748-755

10.1097/sla.0000000000006012 Get It

Objective: This study aims at establishing benchmark values for best achievable outcomes following open major anatomic hepatectomy for liver tumors of all dignities. Background: Outcomes after open major hepatectomies vary widely lacking reference values for comparisons among centers, indications, types of resections, and minimally invasive procedures. Methods: A standard benchmark methodology was used covering consecutive patients, who underwent open major anatomic hepatectomy from 44 high-volume liver centers from 5 continents over a 5-year period (2016–2020). Benchmark cases were low-risk non-cirrhotic patients without significant comorbidities treated in high-volume centers (≥30 major liver resections/year). Benchmark values were set at the 75th percentile of median values of all centers. Minimum follow-up period was 1 year in each patient. Results: Of 8044 patients, 2908 (36%) qualified as benchmark (low-risk) cases. Benchmark cutoffs for all indications include R0 resection ≥78%; liver failure (grade B/C) ≤10%; bile leak (grade B/C) ≤18%; complications ≥grade 3 and CCI ® ≤46% and ≤9 at 3 months, respectively. Benchmark values differed significantly between malignant and benign conditions so that reference values must be adjusted accordingly. Extended right hepatectomy (H1, 4-8 or H4-8) disclosed a higher cutoff for liver failure, while extended left (H1-5,8 or H2-5,8) were associated with higher cutoffs for bile leaks, but had superior oncologic outcomes, when compared to formal left hepatectomy (H1-4 or H2-4). The minimal follow-up for a conclusive outcome evaluation following open anatomic major resection must be 3 months. Conclusion: These new benchmark cutoffs for open major hepatectomy provide a powerful tool to convincingly evaluate other approaches including parenchymal-sparing procedures, laparoscopic/robotic approaches, and alternative treatments, such as ablation therapy, irradiation, or novel chemotherapy regimens.